Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alkermes PLC | ALKS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 24.07 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 24.07 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 22.01 - 33.71 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 24.07 | USD |
Alkermes (ALKS) Options Flow Summary
Alkermes PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.02B | 167.08M | - | 1.66B | 355.76M | 2.13 | 11.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alkermes News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALKS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.02 | 24.59 | 23.48 | 23.90 | 1,938,184 | 0.05 | 0.21% |
| 1 Month | 27.45 | 27.56 | 23.48 | 25.45 | 1,885,096 | -3.38 | -12.31% |
| 3 Months | 28.26 | 32.88 | 23.48 | 27.90 | 2,058,082 | -4.19 | -14.83% |
| 6 Months | 27.25 | 32.88 | 22.01 | 26.89 | 2,330,630 | -3.18 | -11.67% |
| 1 Year | 29.30 | 33.71 | 22.01 | 27.93 | 1,943,411 | -5.23 | -17.85% |
| 3 Years | 21.10 | 33.71 | 20.76 | 26.76 | 1,650,562 | 2.97 | 14.08% |
| 5 Years | 33.50 | 34.97 | 11.98 | 24.08 | 1,547,498 | -9.43 | -28.15% |
Alkermes Description
| Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. |
